Scientist Safety Science, Clinical Pharmacology

Scientist Safety Science, Clinical Pharmacology

Arbetsbeskrivning

We are seeking highly motivated, skilled Scientists with experience in Cell Biology, Automation and human advanced cell models.

You will perform in vitro investigative studies in advanced human cell models to seek a mechanistic understanding of toxicities from projects developing novel medicines, building new in vitro methods predictive of undesired in vivo effects.

You will have the opportunity to work closely with a team of Scientists to apply ground-breaking Imaging and Omics technologies and push the boundaries of predictive safety science with our vision in mind: to deliver innovative safety science to help restore patient's lives.

We are looking for a highly motivated scientist to work within a vibrant group at the leading edge of their field to support drug safety assessments, a critical component of the drug discovery and development process.

About the position

Reponsibilities

You will be a member of the Safety Omics team within the Clinical Pharmacology and Safety Sciences department. Together with other hands-on lab scientists you will apply primary human 2D in vitro and 3D advanced systems to the discovery and development of safe and effective candidate drugs.

Specifically, you will:
Work in close collaboration with Biologists, Omics experts, Computational and AI scientists and other team members to set and answer critical project safety questions
Actively contribute to the experimental design, practical delivery and interpretation of data
Apply your expert knowledge and address capability gaps by contributing to the further development of advanced cell models (kidney, lung)

Your profile

Essential for the role:
A BSc, MSc in cellular biology, pharmacology, toxicology or similar field
Ability to understand biology around advanced human cell models and pathways to drive scientific testing
Strong laboratory-based skills in in vitro and/or advanced cell-based models, particularly kidney and lung models
Expertise in the design and execution of in vitro experiments to determine the effects of molecules on biological systems
Proven experience in laboratory cellular biology techniques applied to development of physiologically relevant cellular assays to evaluate biological mechanisms and high throughput screening (HTS)
Experience with human organoids culture and automation (e.g. kidney and lung models)
An innovative and creative mind-set, combined with scientific excellence and problem-solving skills
Experience of collaborating and communicating effectively with a diverse range of multidisciplinary colleagues
An awareness of new in vitro methodologies through literature and networking
Strong oral presentation and written communication skills
Highly motivated, innovative scientist with a collaborative mentality and a desire to drive personal development

Desirable for the role:
Practical experience and scientific knowledge of in vitro kidney and lung models
Experience of 3D model systems
Understanding of the drug discovery process from experience in the biotech/pharmaceutical industry or collaborations

About the Organisation

This is a consultant assignment at AstraZeneca in Göteborg for 1 year, starting in September 2026.
During the time you will be hired by QRIOS.
Please apply by registering your CV here on our website. Click on the "Ansök" button to the right. It is our recommendation that you register as much information as possible and that you attach a complete CV-document. Please check that your correct e-mail address is registered.

Kontaktpersoner på detta företaget

AstraZeneca

AstraZeneca

AstraZeneca

AstraZeneca

AstraZeneca

AstraZeneca

AstraZeneca

AstraZeneca

AstraZeneca

AstraZeneca

Sammanfattning

  • Arbetsplats: AstraZeneca 0181
  • 1 plats
  • Fast månads- vecko- eller timlön
  • Publicerat: 16 juni 2026
  • Ansök senast: 25 juni 2026

Besöksadress

Pepparedsleden 1
None

Postadress

43183
0181, 43183

Liknande jobb

23 augusti 2010

Forskare

12 april 2010

Postdoktor

6 maj 2010

Senior Pharmacovigilance Scientist

Senior Pharmacovigilance Scientist

21 december 2021